Project Grant R37CA299904
Award Date 9/19/25
Completion Date 8/31/30
Dollars Obligated $652K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Illinois, USA
Similar Awards
- The National Cancer Institute (NCI) awarded a $717,786 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the Children's Hospital Medical Center in Cincinnati, Ohio. The grant will fund a 5-year randomized clinical trial to evaluate the efficacy of the "Supporting Medication Management with Individualized Treatment" (SUMMIT) intervention in improving medication adherence among adolescents and young adults (AYAs) with cancer. SUMMIT is a personalized...
- This Project Grant award, totaling $726,828, was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393). The funding supports a multi-institutional research project to investigate the impact of adverse social and biological interactions on disparities in acute myeloid leukemia (AML) outcomes. Key objectives include developing a neighborhood stress scale, examining the effects of social stress on pre-leukemic TP53 mutations and...
- This federal Project Grant award for $4,236,812 was provided by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to Children's Hospital Los Angeles. The grant supports a study to evaluate a patient navigation intervention for improving transition to adult survivorship care among disadvantaged young adult survivors of childhood cancer. The project aims to address the significant challenges and disparities faced by this population, including high rates of...
- This $530,106 Project Grant was awarded by the National Cancer Institute (NCI) under the Cancer Biology Research federal grant program (CFDA 93.396). The grant aims to target and mechanistically interrogate polyamine metabolism in leukemia stem cells (LSCs) with the long-term objective of developing LSC-directed therapy to improve outcomes for patients with acute myeloid leukemia (AML). The award was made to Childrens Hospital Medical Center in Cincinnati, Ohio, a prominent non-profit...
- This federal Project Grant award of $593,028 was provided by the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) to the Beckman Research Institute of the City of Hope. The award supports research to define the critical role of IL-6/STAT3 signaling in the aggressive CIC-DUX4 fusion-positive sarcomas (CDS), a rare and deadly type of cancer that primarily affects children and young adults. The research aims to determine how the CIC-DUX4 fusion oncoprotein...
- This Project Grant award of $734,435.00 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) aims to advance cancer treatment research for acute myeloid leukemia (AML). The primary recipient, Beckman Research Institute of the City of Hope, will conduct research to investigate how inhibiting the ADSS2 enzyme can sensitize drug-resistant AML to BH3 mimetic therapies. The research will use patient-derived xenograft models to understand the molecular mechanisms underlying...
- The University of Chicago was awarded a $361,807 Project Grant by the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to tailor and pilot a technology-assisted cognitive behavioral therapy (TCBT) program for adolescents and young adults (AYAs) with hematological malignancies. The grant, titled "Tailoring a Fun and Engaging Tech-Assisted Cognitive Behavioral Therapy Program for Adolescents and Young Adults with Hematological Malignancies: A Planning Grant", aims to...
- The National Cancer Institute awarded a $185,693 Project Grant titled "A Digital Health Parent Coaching Intervention to Improve Neurodevelopmental Outcomes for Young Childhood Cancer Survivors in Underserved Communities" under the Cancer Research Manpower (CFDA 93.398) federal grant program. The grant recipient, the Research Institute at Nationwide Children's Hospital, will conduct research to develop a digital health intervention to support parents of young childhood cancer...
- The National Cancer Institute (NCI) awarded a $772,418 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to St. Jude Children's Research Hospital Inc. The grant, titled "Evaluation of Cardiovascular Health Outcomes Among Survivors 2 (ECHOS-2)", will test the efficacy of an eHealth-delivered intervention to improve adherence to cardiomyopathy screening among adult survivors of childhood cancer. The study aims to address the poor adherence rates for...
- The National Cancer Institute (NCI), a component of the Department of Health and Human Services National Institutes of Health, awarded a $319,505 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program to the Regents of the University of Michigan. The grant, awarded on Aug 1, 2025, will fund a 5-year project to build nationwide investigator capacity in methods for adapting and personalizing cancer control interventions. The project aims to deliver comprehensive...